Neuros to launch pivotal trial for neuromodulation device; FDA clears Maquet's surgical lighting system;

@FierceMedDev: Medtronic jumps into hemodialysis business through India partnership. ICYMI yesterday | Follow @FierceMedDev

@MarkHFierce: The head of Roche molecular diagnostics spoke to FierceDiagnostics recently about two key future products. More | Follow @MarkHFierce

@MichaelGFierce: Check out this week's FierceDrugDelivery newsletter! RNAi roundup & stem cell drug delivery action. Report | Follow @MichaelGFierce

> Neuros Medical secured the FDA's blessing to conduct a pivotal trial of its Altius neuromodulation device, which treats the intractable limb pain of amputees. More

> CardioDx's Corus CAD test is especially effective in women, according to a new study, providing early detection of obstructive coronary artery disease that could save more than $500 in medical costs per patient. Release

> Maquet picked up FDA clearance for its Volista surgical lighting system. News

> Florida's OrthoSenso gained a CE mark for Verasense, a sensor-based device designed to give surgeons data to help reduce misalignment and imbalance in a total knee replacement procedure. Item

> Integra LifeSciences Holdings ($IART) said it won 510(k) clearance for a set of new implants and instruments designed for use after open-door laminoplasty procedures in the cervical and thoracic spine. Item

> Sotera Wireless won FDA clearance for its new continuous non-invasive blood pressure technology, a key feature of its wireless patient monitoring system. Item

Biotech News

@FierceBiotech: Popular yesterday: 10 top drugs in biopharma's late-stage pipeline. Feature | Follow @FierceBiotech

@JohnCFierce: Few months after $60M C series and Forest deal, Trevena files for $86M IPO. SEC filing | Press release | Follow @JohnCFierce

@DamianFierce: MacroGenics has up-sized its IPO, now seeking $80M amid biotech blitz. ICYMI yesterday | Follow @DamianFierce

@EmilyMFierce: 3-D printing builds bacterial metropolises. More via ScienceNews | Follow @EmilyMFierce

> Google visionaries ready to invest a fortune in revolutionizing aging process. Article

> Takeda punts $620M antibody licensing pact with Immunomedics. Story

> Gilead scores early PhIII success for idelalisib in chronic lymphocytic leukemia. More

Pharma News

@FiercePharma: Top 10 Drugmakers in Emerging Markets--our latest special report. Feature | Follow @FiercePharma

@CarlyHFierce: Teva: Copying GlaxoSmithKline's Advair too tough for success before 2018. ICYMI yesterday | Follow @CarlyHFierce

> Which new drugs promise to shake up markets the most? Report

> Express Scripts stops covering key Big Pharma drugs on cost-effectiveness grounds. Story

> Teva plots 5,000 more job cuts in $2B savings drive. News

Pharma Manufacturing News

@EricPFierce: Will McKesson and AmerisourceBergen now face off in Europe? Article | Follow @EricPFierce

> Catalent moves on Brazil VMS, softgel market. News

> Vetter putting $100M into its production network. Report

> Teva looks for big savings from procurement, manufacturing. Story

> Feds fight drug imports Maine now allows. More

> BioCentury finds FDA has $270M in GDUFA, PDUFA fees in hand. Item

Vaccines News

> WHO prequalification moves China into global vaccine arena. Item

> Novartis opening vaccine R&D lab in North Carolina. Report

> Takeda's norovirus vaccine misses endpoint in early-phase trial. Story

> GSK targets 2015 launch for malaria vaccine. Article

> HIV trial follow-up quashes fears of infection risk. More